JP2024519668A5 - - Google Patents

Info

Publication number
JP2024519668A5
JP2024519668A5 JP2023562806A JP2023562806A JP2024519668A5 JP 2024519668 A5 JP2024519668 A5 JP 2024519668A5 JP 2023562806 A JP2023562806 A JP 2023562806A JP 2023562806 A JP2023562806 A JP 2023562806A JP 2024519668 A5 JP2024519668 A5 JP 2024519668A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutical composition
dendrimer
cancer
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023562806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/024752 external-priority patent/WO2022221490A1/en
Publication of JP2024519668A publication Critical patent/JP2024519668A/ja
Publication of JP2024519668A5 publication Critical patent/JP2024519668A5/ja
Pending legal-status Critical Current

Links

JP2023562806A 2021-04-14 2022-04-14 デンドリマー－グルタミンアンタゴニストコンジュゲートおよびそれを使用する方法 Pending JP2024519668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163174878P 2021-04-14 2021-04-14
US63/174,878 2021-04-14
PCT/US2022/024752 WO2022221490A1 (en) 2021-04-14 2022-04-14 Dendrimer-glutamine antagonist conjugates and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024519668A JP2024519668A (ja) 2024-05-21
JP2024519668A5 true JP2024519668A5 (https=) 2025-04-16

Family

ID=83640697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023562806A Pending JP2024519668A (ja) 2021-04-14 2022-04-14 デンドリマー－グルタミンアンタゴニストコンジュゲートおよびそれを使用する方法

Country Status (4)

Country Link
US (1) US20240398962A1 (https=)
EP (1) EP4322961A1 (https=)
JP (1) JP2024519668A (https=)
WO (1) WO2022221490A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024151843A1 (en) * 2023-01-11 2024-07-18 The Johns Hopkins University Targeted universal delivery system of don and other drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842763B2 (en) * 2015-07-31 2020-11-24 The Johns Hopkins University Methods for cancer and immunotherapy using prodrugs of glutamine analogs

Similar Documents

Publication Publication Date Title
CN101420963B (zh) 用于治疗乳腺癌、结肠直肠癌、胰腺癌、卵巢癌和肺癌的7-乙基-10-羟基喜树碱的多臂聚合轭合物
ES2978534T3 (es) Análogos de éter de fosfolípidos como vehículos de fármacos contra el cáncer
CN112245591B (zh) 化疗药物-低氧激活前药一体化前药自组装纳米粒的构建
CN101605539B (zh) 用7-乙基-10-羟基喜树碱的多臂聚合缀合物治疗抵抗性或顽固性癌症
CN101707888A (zh) 用7-乙基-10-羟基喜树碱的多臂聚合物缀合物治疗非霍奇金氏淋巴瘤
JP7588065B2 (ja) 治療用デンドリマー
CN102215688A (zh) 用7-乙基-10-羟基喜树碱的多臂聚合物对神经母细胞瘤的治疗
CN110092775B (zh) 靶向cdk4/6激酶抑制剂的晶型
JP2010043114A (ja) 腫瘍転移および癌の治療
CN111484501A (zh) 羟基喜树碱亚油酸酯小分子前药及其自组装纳米粒的构建
JP6656397B2 (ja) 抗腫瘍薬物の効果を有する併用薬物
JP7506659B2 (ja) 癌を処置する方法に用いられるコンジュゲート
JP2024519668A5 (https=)
CN111671771B (zh) 靶向dna大沟并抑制拓扑异构酶的石墨烯碱及其制法和用途
JP2022544559A5 (https=)
CN117396227A (zh) siRNA递送载体
CN101466387A (zh) 镓(ⅲ)络合物在黑素瘤治疗中的应用
JP5843086B2 (ja) 治療活性物質の作用を増強するための高分子化環状ニトロキシドラジカル化合物の使用
CN107001617B (zh) Peg衍生物
JP7506660B2 (ja) デンドリマー製剤
CN110698491B (zh) 2-(喜树碱-10-氧基)乙酰胺类化合物和应用
CN117017947B (zh) 一种肿瘤细胞膜包被富勒烯的纳米材料及其制备方法和应用
JP2021518336A (ja) 上咽頭がん治療用キノリン誘導体
CN108096255B (zh) 地夫可特用于抑制或治疗胰腺癌的用途
WO2025209442A1 (zh) 偶联物在治疗肿瘤疾病中的用途及方法